CONDENSED CONSOLIDATED STATEMENTS OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue
Total revenue	$ 49,169	$ 49,257	$ 95,973	$ 94,100
Cost of revenue
Cost of revenue	15,287	15,828	28,654	29,705
Selling, general, and administrative	27,649	25,760	50,659	48,845
Income from operations	6,233	7,669	16,660	15,550
Other income (expense) net :
Interest expense, net	(2,577)	(1,645)	(4,237)	(3,291)
Loss from change in fair value of warrant liability		(11,793)		(13,411)
Loss from change in fair value of earnout liability	(13,949)	(6,400)	(26,038)	(31,810)
Other income (expense)	(2)	(4)	(4)	(11)
Total other income (expense), net	(16,528)	(19,842)	(30,279)	(48,523)
Loss before provision for income taxes	(10,295)	(12,173)	(13,619)	(32,973)
Income tax expense	180	922	2,666	1,552
Net loss	(10,475)	(13,095)	(16,285)	(34,525)
Less: Net loss attributable to noncontrolling interest	(4,153)	(7,952)	(7,893)	(22,577)
Net loss attributable to biote Corp. stockholders	(6,322)	(5,143)	(8,392)	(11,948)
Other comprehensive income (loss):
Foreign currency translation adjustments	(1)		(2)
Other comprehensive income (loss)	(1)		(2)
Comprehensive income (loss)	$ (10,476)	$ (13,095)	$ (16,287)	$ (34,525)
Net loss per common share
Basic	$ (0.19)	$ (0.25)	$ (0.25)	$ (0.62)
Diluted	$ (0.19)	$ (0.25)	$ (0.25)	$ (0.62)
Weighted average common shares outstanding
Basic	33,072,156	20,704,866	34,185,578	19,153,574
Diluted	33,072,156	20,704,866	34,185,578	19,153,574
Product Revenue
Revenue
Total revenue	$ 48,111	$ 48,652	$ 94,146	$ 92,807
Cost of revenue
Cost of revenue	14,426	14,992	27,228	28,019
Service Revenue
Revenue
Total revenue	1,058	605	1,827	1,293
Cost of revenue
Cost of revenue	$ 861	$ 836	$ 1,426	$ 1,686